SARS-CoV-2 infection in children younger than 10 years of age has been described in around 1% of identified cases in China [1]. Although data on children is still limited, most series agree that cases are mostly mild, even in infants [2, 3]. Very little information is available about pediatric patients with underlying diseases, and data in children with immunosuppression is almost non-existent. COVID-19 serious disease has been described in a child with post-chemotherapy agranulocytosis due to acute leukemia [4]. Preliminary data from Bergamo [5] indicates that in Italy, practically no cases of infection have been detected in immunosuppressed patients (3 mild cases), which has led them to consider that this group of patients is not a high-risk group for COVID-19 disease.